These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30818883)

  • 1. Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors.
    Huang K; Jiang L; Li H; Ye D; Zhou L
    Molecules; 2019 Feb; 24(5):. PubMed ID: 30818883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
    Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
    Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
    Jiang K; Gao B; Yu J; Jiang L; Niu A; Jia Y; Meng T; Zhou L; Wang J
    Bioorg Med Chem Lett; 2021 Mar; 36():127820. PubMed ID: 33513389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
    Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
    Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Design and Synthesis of
    Wang P; Jiang L; Cao Y; Ye D; Zhou L
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.
    Huang K; Liang Q; Zhou Y; Jiang LL; Gu WM; Luo MY; Tang YB; Wang Y; Lu W; Huang M; Zhang SZ; Zhuang GL; Dai Q; Shen QC; Zhang J; Lei HM; Zhu L; Ye DY; Chen HZ; Zhou L; Shen Y
    Cell Metab; 2019 Dec; 30(6):1107-1119.e8. PubMed ID: 31607564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, suppresses invasive pseudopodia formation and upregulates plasminogen activator inhibitor-2 in erlotinib-resistant non-small cell lung cancer cells.
    Liang Q; Gu WM; Huang K; Luo MY; Zou JH; Zhuang GL; Lei HM; Chen HZ; Zhu L; Zhou L; Shen Y
    Acta Pharmacol Sin; 2021 Jan; 42(1):115-119. PubMed ID: 32404981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma.
    Wen CL; Huang K; Jiang LL; Lu XX; Dai YT; Shi MM; Tang XM; Wang QB; Zhang XD; Wang PH; Li HT; Ruan XX; Wang LW; Wang XJ; Wang Q; Lu W; Xiang XQ; Sun X; Xu YH; Lai LH; Zhan Q; Li HW; Peng CH; Chen J; Huang JY; Ye DY; Chen SJ; Chen Z; Li M; Fang Y; Shen BY; Zhou L
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23264-23273. PubMed ID: 31662475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
    Jiang X; Sun Q; Li H; Li K; Ren X
    Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
    Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
    Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-Selective Phosphoglycerate Mutase 1 Acetylation by a Small Molecule.
    Zhang X; Jiang L; Huang K; Fang C; Li J; Yang J; Li H; Ruan X; Wang P; Mo M; Wu P; Xu Y; Peng C; Uesugi M; Ye D; Yu FX; Zhou L
    ACS Chem Biol; 2020 Mar; 15(3):632-639. PubMed ID: 32069008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
    Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
    IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anthraquinone amide derivatives as potential glyoxalase-I inhibitors.
    Al-Akeedi M; Najdawi M; Al-Balas Q; Al-Qazzan MB; Telfah ST
    J Med Life; 2024 Jan; 17(1):87-98. PubMed ID: 38737655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
    Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
    Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.
    Li X; Tang S; Wang QQ; Leung EL; Jin H; Huang Y; Liu J; Geng M; Huang M; Yuan S; Yao XJ; Ding J
    Front Pharmacol; 2017; 8():325. PubMed ID: 28611670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
    Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
    Nat Commun; 2013; 4():1790. PubMed ID: 23653202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation and dynamics of the C-terminal region in human phosphoglycerate mutase 1.
    Liu SE; Hu JC; Zhang H; Xu P; Wan W; Zheng MY; Yu KQ; Ding H; Jiang HL; Zhou L; Luo C
    Acta Pharmacol Sin; 2017 Dec; 38(12):1673-1682. PubMed ID: 28748916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors.
    Wang Y; Guo Y; Qiang S; Jin R; Li Z; Tang Y; Leung ELH; Guo H; Yao X
    Front Pharmacol; 2021; 12():764351. PubMed ID: 34899321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules.
    Lee YR; Yu DS; Liang YC; Huang KF; Chou SJ; Chen TC; Lee CC; Chen CL; Chiou SH; Huang HS
    PLoS One; 2013; 8(2):e56284. PubMed ID: 23451039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
    Yang GL; Zhao SF; Chen NY; Li S
    Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.